Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Serko Limited Director's Dealing 2025

Aug 4, 2025

66271_rns_2025-08-05_ca36f475-d4ce-4a1e-9616-7381e01eff54.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [134 x 34] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

==> picture [549 x 646] intentionally omitted <==

----- Start of picture text ----- To NZX Limited; andName of listed issuer: Serko LimitedDate this disclosure made: 4 August 2025Date of last disclosure: 29 November 2024Director or senior manager giving disclosureFull name(s): Robert Clyde McConaghyName of listed issuer: Serko LimitedName of related body corporate (if applicable): Not applicablePosition held in listed issuer: Previous DirectorSummary of acquisition or disposal of relevant interest (excluding specified derivatives)Class of affected quoted financial products: Ordinary shares in Serko LimitedNature of the affected relevant interest(s): Registered holder and beneficial ownerof shares by virtue of Mr McConaghybeing a trustee (and beneficiary) of thePortofino Trust.For that relevant interest-Number held in class before acquisition or disposal: 153,003.00Number held in class after acquisition or disposal: 143,003.00Current registered holder(s): Mr McConaghy as trustee for PortofinoTrustRegistered holder(s) once transfers are registered: UnknownDetails of transactions giving rise to acquisition or disposalTotal number of transactions to which notice relates: 1-Details of transactions requiring disclosureDate of transaction: 30 July 2025Nature of transaction: On-market share saleName of any other party or parties to the transaction (if known): Not applicable.The consideration, expressed in New Zealand dollars, paid or received for the acquisition ordisposal. If the consideration was not in cash and cannot be readily by converted into a cashvalue, describe the consideration:$2.86 per shareNumber of financial products to which the transaction related: 10,000 ordinary sharesIf the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period) include—the following detailsWhether relevant interests were acquired or disposed of during a closed period: NoWhether prior written clearance was provided to allow the acquisition or disposal to proceed Not applicableduring the closed period:Date of the prior written clearance (if any): Not applicableSummary of other relevant interests after acquisition or disposal:Class of quoted financial products: Ordinary shares----- End of picture text -----

Nature of relevant interest:

Registered holder and beneficial owner 1,091 Robert Clyde McConaghy

- For that relevant interest, Number held in class: 1,091 Current registered holder(s): - For a derivative relevant interest, Type of derivative: Not applicable - Details of derivative, The notional value of the derivative (if any) or the notional amount of underlying financial Not applicable products (if any): A statement as to whether the derivative is cash settled or physically settled: Not applicable Maturity date of the derivative (if any): Not applicable Expiry date of the derivative (if any): Not applicable The price's specified terms (if any): Not applicable Any other details needed to understand how the amount of the consideration payable under Not applicable the derivative or the value of the derivative is affected by the value of the underlying financial products: - For that derivative relevant interest, Parties to the derivative: Not applicable If the director or senior manager is not a party to the derivative, the nature of the relevant Not applicable interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of person authorised to sign on behalf of director or officer: Date of signature: 1-Aug-25 Name and title of authorised person: Isla Dentice-Wood, Company Secretary